Epidemiology of Pancreatic Cancer- Market Access, Statistics, Comprehensive Insights for Stakeholders and Regulatory Guidelines | Disease Landscape Insights

Epidemiology of Pancreatic Cancer- Market Access, Statistics, Comprehensive Insights for Stakeholders and Regulatory Guidelines | Disease Landscape Insights

LONDON, Sept. 25, 2023 /PRNewswire/ — Pancreatic Cancer is one of the highly prevalent types of cancer worldwide. In fact, it has been regarded as the fourth leading cause of deaths among both men and women. According to a epidemiology study conducted by the NIH, pancreatic cancer represents 2.5% of all cancers. The alarming rise in the disease burden is pushing medical researchers and other concerned bodies to develop effective treatment for pancreatic cancer. Widespread advancements in the healthcare sector coupled with increased health cognizance among the masses is further paving the way for highly improved cancer diagnostic, prevention, and treatment scenario.


Pancreas is an organ located in the upper left abdomen and is surrounded by the liver, spleen, and gallbladder. It produces vital digestive enzymes and also sends out hormones that help in sugar regulation within the bloodstream. The uncontrollable cell growth within the pancreas, leading to the formation of a mass or tumor is referred to as pancreatic cancer. Asenocarcinoma pancreatic cancer and neuroendocrine pancreatic cancer are the two types of pancreatic cancer. DiseaseLandscape Insights has been offering comprehensive healthcare consulting services to the players operating in this vertical. It excels in delivering a wide range of services that empower healthcare professionals, pharmaceutical companies, and medical researchers. Its expertise spans from drug insights, new product launch services to pricing and market access strategies, just to name a few.

Disease Overview- Primary Symptoms and Causes-

The symptoms of pancreatic cancer may vary from person to person. They may often be similar to with other, less serious conditions. But some of the common symptoms of pancreatic cancer are abdominal pain, unexplained weight loss, diabetes, dark urine, loss of appetite, and greasy stools, among others.  

Price and Market Access

DLI has been playing a pivotal role in aiding healthcare stakeholders to comprehensively understand pancreatic disease symptoms, characteristics, and the development of effective diagnostic and treatment methodologies. It further helps in treatment gap identification, leading to advanced drug development. DLI further provides valuable symptom profiling, shedding light on the progression of symptoms in pancreatic diseases, which is instrumental in enhancing diagnostic accuracy and refining treatment strategies.

Pancreatic cancer is predominantly triggered by rising age, excessive tobacco consumption, high alcohol intake, presence of co-morbidities like diabetes, obesity, unhealthy dietary habits, exposure to toxic chemicals, family history, along with genetic defects, among others. Lifestyle modifications can work wonders in preventing the onset of this ailment. However, once diagnosed, a patient requires to undergo a number of treatment to alleviate the symptoms.

Learn More About the FDA NDA & BLA Approval (NME) Drugs for Pancreatic Cancer @


Diagnostic Landscape of Pancreatic Cancer-

Early detection and intervention can significantly improve the outlook for pancreatic cancer. Due to the similarity of its symptoms with other non-cancerous conditions, confirming its presence in the patient’s body can be quite difficult, especially when it is in its early stage.

Pancreatic cancer diagnostics involve a series of tests and procedures including-

Medical History and Physical Examination:

A thorough medical history and physical examination by a healthcare provider can help identify potential risk factors and initial signs of pancreatic cancer.

Blood Tests:

Blood tests may be conducted to check for specific markers, such as elevated levels of CA 19-9 or CEA (carcinoembryonic antigen), which can be associated with pancreatic cancer. However, these markers are not specific to pancreatic cancer and can be elevated in other conditions as well.

Imaging Tests: 

Various imaging techniques are used to visualize the pancreas and surrounding tissues, including CT (Computed Tomography) Scan, MRI (Magnetic Resonance Imaging), Endoscopic Ultrasound (EUS), PET (Positron Emission Tomography) Scan, and Biopsy, among others.

Endoscopic Retrograde Cholangiopancreatography (ERCP): 

This procedure can help diagnose pancreatic cancer by visualizing the pancreas and its ducts. It can also be used to obtain tissue samples.

Discover More About Pricing and Reimbursement, Epidemiology Study, and Healthcare @



In some cases, a laparoscopy may be performed to examine the abdomen and obtain tissue samples for diagnosis.

Genetic Testing:

Genetic testing may be recommended to check for inherited genetic mutations associated with an increased risk of pancreatic cancer, such as BRCA1, BRCA2, or PALB2 mutations.


Once pancreatic cancer is confirmed, further tests may be done to determine the stage of the cancer, which helps guide treatment decisions.

Treatment Scenario

The treatment landscape of this disease consists of various types of medical intervention. Pancreatic cancer stage, symptoms, age of the patients, along with their overall health status are thoroughly assessed by oncologists before making any treatment decisions.

Pancreas surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy, among others are some of the effective treatment methods. Different type of pancreatic tumors including pancreatic cancer metastasis to liver, pancreatic endocrine tumor, pancreatic neoplasm, pancreatic neuroendocrine tumor are treated using diverse treatment techniques.

DLI has been aiding players in their endeavours to develop highly advanced treatment methods to treat this devastating ailment. It has been helping them with clinical trial management, drug launch strategies, pricing and reimbursement, commercial strategy analysis, and product portfolio analysis while offering them comprehensive regulatory consulting services.

By leveraging DLI’s deep dive pancreatic cancer research expertise, related players are being able to solidify their position in this vertical. They are accelerating their R&D process with an aim to bring about the much-needed transformation in the pancreatic cancer care domain.

Unlock the Benefits Today! Get Started Now and Elevate Your Experience @


Final Words-

Pancreatic cancer is a dreadful ailment that has a high mortality rate. It affects a significant portion of the world’s population. Unhealthy lifestyle habits, excessive smoking, fast food consumption, food adulteration, and genetic factors are some of the primary reasons triggering the onset of this ailment. Healthcare experts, researchers, and pharma companies, among others are taking extensive efforts to develop cutting edge diagnostic and treatment solutions. DLI has been serving as an invaluable compass, guiding healthcare players through the intricate terrain of pancreatic cancer management. Its expertise, driven by data analysis, research capabilities, and a profound understanding of the disease, empowers stakeholders to navigate the complexities of drug development, market access, and regulatory compliance with precision. DLI’s contributions extend far beyond consultancy as it facilitates progress, fosters hope, and ultimately strives to enhance the lives of those affected by this challenging disease.

Related Reports:

Global Landscape of Lung Cancer Services: Insights and Trends

Monkeypox Unveiled: Symptoms, Transmission, and Preventive Measures

Pneumonia Demystified: Symptoms, Causes, and Prevention Strategies

Understanding Lupus: Navigating the Complex Autoimmune Disorder

Comprehensive Guide to Ringworm: Symptoms, Causes, and Effective Treatment

Comprehensive Guide to Diverticulitis: Symptoms, Causes, and Solutions

Regulatory Insights, Disease Landscape, and Market Access Expertise are some of the areas we help you grasp when it comes to strategic Diabetes Disease consulting.

With specialized market entrance techniques, find solutions to HPV disease. Advice on clinical trials and FDA/EMA insights. Investigate now!

Get market insights on Anemia Disease, including KOLs, the FDA, epidemiology, price reimbursement, and more. Your reliable resource for information about anemia. Investigate now!

Symptoms, prevention, and market research on the Chlamydia Disease. Follow updates from the FDA and EMA, epidemiology research, and market entrance strategies.

the Ovarian Cancer Disease market using our tried-and-true tactic. Learn to identify your product’s important opinion leaders, to negotiate the regulatory process, and to set a fair pricing.

Navigating Solid Tumor Diseases: Insights and Consulting Services

Demodex Blepharitis: Unveiling Insights and Consulting Services

Unveiling Hope: Navigating Duchenne Muscular Dystrophy (DMD)

Unlocking Relief: Effective Psoriasis Disease Management Strategies

Revolutionizing Parkinson’s Disease Care: Global Insights and Innovations

Unlocking the Latest Breakthroughs in Alzheimer’s Disease Research: Hope on the Horizon

Rising Against the Odds: Global Insights into Multiple System Atrophy (MSA) Disease

About Disease Landscape:  

Disease Landscape, a pioneering company specializing in Disease Intelligence, Pricing, and Market Access. Utilizing the power of data analytics, Disease Landscape Insights is dedicated to healthcare sector with invaluable, finely crafted insights and recommendations regarding global pricing and market access strategies. As a specialized firm, we are committed to delivering unparalleled insights into pricing and market access, custom-tailored to the healthcare and pharmaceutical industries. Our data-driven solutions and cutting-edge technology position us as your trustworthy partner, offering swift, adaptable, and evidence-based alternatives to traditional market access and pricing research methods.  

Our core competencies encompass Market Research Services, Consulting Services, Global Pricing and Market Access, Epidemiology Studies, as well as Product Portfolio and Pipeline Services. Our expertise lies in furnishing comprehensive data intelligence throughout every phase of drug and device research.  

Contact Us:

Disease Landscape Insights LLP

6th Floor, Sr No.207, Office A H 6070 Phase 1

Solitaire Business Hub, Viman Nagar

Pune, Maharashtra, 411014

Email: [email protected]

Email: [email protected]

Blog: https://www.diseaselandscape.com/blogs

Case Study: https://www.diseaselandscape.com/casestudies

Pharma consulting Services

Follow Us: LinkedIn | Twitter | Facebook

Corporate Sales: +44-2038074155 

Asia Office: +917447409162

Logo: https://mma.prnewswire.com/media/2217060/Disease_Landscape_Insights_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/epidemiology-of-pancreatic-cancer–market-access-statistics-comprehensive-insights-for-stakeholders-and-regulatory-guidelines–disease-landscape-insights-301937134.html

rt Epidemiology of Pancreatic Cancer- Market Access, Statistics, Comprehensive Insights for Stakeholders and Regulatory Guidelines | Disease Landscape Insights

Featured image: Megapixl © Rolffimages